CN Patent

CN108430581A — 用于利扎曲普坦的药物组合物

Assigned to Dr Reddys Laboratories Ltd · Expires 2018-08-21 · 8y expired

What this patent protects

本发明涉及通过给药含于单位剂量中的包含利扎曲普坦或其药物学可接受的盐药物组合物来治疗患者中的偏头痛的方法。

USPTO Abstract

本发明涉及通过给药含于单位剂量中的包含利扎曲普坦或其药物学可接受的盐药物组合物来治疗患者中的偏头痛的方法。

Drugs covered by this patent

sumatriptan-succinate (SUMATRIPTAN SUCCINATE)

Patent Metadata

Patent number: CN108430581A
Jurisdiction: CN
Classification: —
Expires: 2018-08-21
Drug substance claim: No
Drug product claim: No
Assignee: Dr Reddys Laboratories Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.